Canakinumab Subcutaneous and Fenofibrate and Derivatives Capsules
Determining the interaction of Canakinumab Subcutaneous and Fenofibrate and Derivatives Capsules and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: canakinumab
Brand name: Ilaris
Synonyms: Canakinumab
Generic Name: fenofibrate
Brand name: Antara, Fenoglide, Lipofen, Tricor, Triglide, Lipidil Micro, Dom-Fenofibrate, Lipidil Supra, Lofibra, Lipidil EZ
Synonyms: Fenofibrate, Fenofibrate and Derivatives
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Canakinumab Subcutaneous-Fenofibrate and Derivatives Tablets
- Canakinumab Subcutaneous-Fenofibrate Capsules
- Canakinumab Subcutaneous-Fenofibrate Tablets
- Canakinumab Subcutaneous-Fenofibric acid
- Canakinumab Subcutaneous-Fenofibric Acid Delayed Release Capsules
- Canakinumab Subcutaneous-Fenofibric Acid/Fenofibrate
- Fenofibrate and Derivatives Capsules-Canasa
- Fenofibrate and Derivatives Capsules-Canasa Pac rectal
- Fenofibrate and Derivatives Capsules-Canasa rectal
- Fenofibrate and Derivatives Capsules-Cancidas
- Fenofibrate and Derivatives Capsules-Candesartan
- Fenofibrate and Derivatives Capsules-Candesartan and Hydrochlorothiazide